首页> 外文OA文献 >Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients

【2h】

Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients

机译：器官移植受者引起的EBV +和EBV-淋巴增生性疾病的自体淋巴因子激活的杀手（LAK）细胞疗法

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nalesnik MA; Rao AS; Furukawa H; Pham S; Zeevi A; Fung JJ; Klein G; Gritsch A; Elder E; Whiteside TL; Starzl TE;
展开▼
作者单位

展开▼
年度 1997
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Adoptive Therapy with EBV-Specific T Cells for Treatment of CNS EBV Post-Transplant Lymphoproliferative Disease Arising after Hematopoietic Stem Cell Transplant or Solid Organ Transplant [J] . Prockop Susan, Suser Stephanie, Doubrovina Ekaterina, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：用EBV特异性T细胞的采用疗法治疗造血干细胞移植或固体器官移植后产生的CNS EBV后移植后淋巴抑制性疾病
2. Successful treatment of post-transplant lymphoproliferative disorder in autologous blood stem cell transplant recipients. [J] . Jenkins D, DiFrancesco L, Chaudhry A, Bone marrow transplantation . 2002,第5期

机译：成功治疗自体血干细胞移植受者的移植后淋巴细胞增生性疾病。
3. Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patients. [J] . Fujimiya Y, Suzuki Y, Katakura R, Journal of hematotherapy . 1999,第1期

机译：由胶质母细胞瘤患者外周血单核细胞体外产生的淋巴因子激活的杀伤（LAK）细胞介导的自体正常组织和肿瘤的损伤。
4. HIGH-DOSE MELPHALAN CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN 65 PATIENTS WITH AL AMYLOIDOSIS: ORGAN PROGRESSION CAN BE DELAYED IN PATIENTS REACHING COMPLETE REMISSION [C] . SO Schonland, J.B Dengler, M Hundemer, International Symposium on Amyloidosis . 2008

机译：在65例Al淀粉样蛋白患者中，具有自体蛋白化疗的高剂量蛋白化疗：器官进展可以延迟达到完全缓解的患者
5. Murine Lymphokine-activated Killer(LAK)Cells: Establishment of LAK Cell Clones,Analysis of Target Cell Killing Mechanism and Application for Tumor Therapy [D] . 加藤和則 1991

机译：小鼠淋巴因子激活的杀伤（LAK）细胞：LAK细胞克隆的建立，靶细胞杀伤机制的分析及其在肿瘤治疗中的应用
6. AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF EPSTEIN-BARR VIRUS-POSITIVE AND -NEGATIVE LYMPHOPROLIFERATIVE DISORDERS ARISING IN ORGAN TRANSPLANT RECIPIENTS [O] . Michael A. Nalesnik, Abdul S. Rao, Hiro Furukawa, -1

机译：器官移植受体引起的上皮性淋巴因子激活的杀手细胞杀死上皮性蛋白-BARR病毒阳性和阴性的淋巴增生性疾病。
7. Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients [O] . Nalesnik MA, Rao AS, Furukawa H, 1997

机译：器官移植受者引起的EBV +和EBV-淋巴增生性疾病的自体淋巴因子激活的杀手（LAK）细胞疗法

Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients

著录项

引文网络

相似文献

相关主题

期刊订阅